About Hospital General de México; Unidad de Oncologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Clinical Trials at Hospital General de México; Unidad de Oncologia
During the past decade, Hospital General de México; Unidad de Oncologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Study of Pertuzumab in Combination With Trastuzumab (Herceptin) and a Taxane in First-Line Treatment in Participants With Human Epidermal Growth Factor 2 (HER2)-Positive Advanced Breast Cancer
2012-06-01
2019-09-20
Completed
1,436
A Study of Trastuzumab Emtansine Versus Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
2012-09-03
2016-04-30
Terminated
415
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General de México; Unidad de Oncologia"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Hospital General de México; Unidad de Oncologia
According to Clinical.Site data, the most researched conditions in "Hospital General de México; Unidad de Oncologia" are
"Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Gastric Cancer" (1 trials) and "Malignant Melanoma" (1 trials). Many other conditions were trialed in "Hospital General de México; Unidad de Oncologia" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General de México; Unidad de Oncologia
Most popular intervention types in "Hospital General de México; Unidad de Oncologia" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials), "Trastuzumab" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General de México; Unidad de Oncologia
The vast majority of trials in "Hospital General de México; Unidad de Oncologia" are
4 trials for "All" genders.
Clinical Trials Status at Hospital General de México; Unidad de Oncologia
Currently, there are NaN active trials in "Hospital General de México; Unidad de Oncologia".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hospital General de México; Unidad de Oncologia,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General de México; Unidad de Oncologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".